Apr 22, 2009 | Med Ad News
For Atrial Fibrillation, Surveyed Experts Indicate That Multaq,...
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed cardiologists identify a therapy's effect on mortality as the attribute that most influences their prescribing decisions in maintenance of normal sinus rhythm in atrial fibrillation.
Inhaled asthma drug hits sour note
Q: I am a singer, so my voice is critical to both my livelihood and my sense of well-being. I was recently diagnosed with mild asthma, and my doctor prescribed an inhaler called Flovent.
FDA says Sanofi-Aventis drug can reduce hospitalizations linked to heart defect
The Food and Drug Administration says an experimental drug from Sanofi-Aventis could significantly decrease hospitalizations caused by irregular heart rhythms.
Drug Watch: News About Statin Drugs
* The FDA is reminding practitioners that concurrent use of simvastatin and the antiarrhythmic drug amiodarone can increase the risk of rhabdomyolysis, a rare but possibly fatal muscle disease.
Reno judge sets precedent, allows plaintiff's doctor to be questioned
A Reno federal judge hearing a wrongful death case against a pharmaceutical company Tuesday set what one lawyer called "a dangerous precedent" by saying that state laws and the federal privacy act do not ...
Clopidogrel bisulfate January 26, 2009 Healthcare providers should continue to prescribe and patients should continue to take clopidogrel as directed, because... Topical Anesthetics January 16, 2009 Audience: ...
Health Tip: Health Tip: Wine Could Benefit the Heart
Excessive drinking offers no benefits whatsoever, but having a single glass of red wine each day could help the heart, the U.S. Library of Medicine says.
Riastap Approved for Rare Blood Disorder
The U.S. Food and Drug Administration has approved Riastap to treat a blood disorder caused by a rare genetic condition.
Health Tip: Dental Visits for Older Patients
Epiduo Epiduo Gel is a once-daily, topical acne treatment that combines the well-tolerated retinoid adapalene, and benzoyl peroxide, a well-known antimicrobial.
CyDex Pharmaceuticals Announces CAPTISOL Technology Used in Recently ...
CyDex Pharmaceuticals, Inc. today announced that Prism Pharmaceuticals' NEXTERONE , which recently received new drug application approval from the U.S. Food and Drug Administration , is based on the ...
Health Tip: Budget Your Calories
The U.S. Department of Agriculture suggests that you budget calories the way you do money -- in general, don't use more than you need.
Prism gets FDA nod for NEXTERONE for ventricular fibrillation and ventricular tachycardia
The approval triggers a second USD 10 million milestone payment from Paul Capital.
Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for...
NEXTERONE is indicated for the treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy.